Tag Archives: Drug

Viewpoints: The FDA Isn’t Up To The Task Of Reining In The Opioid Epidemic; The Downside Of Taking Children From Parents In Drug Treatment

Editorial writers weigh in on these and other health care topics. The Washington Post: This Is Why The Federal Government Has A Hard Time Regulating Prescription Opioids This past week, President Trump argued on national television that to end the opioid epidemic, Congress needed to fund the building of a wall at the United States’… Read More »

‘The results were impressive’: Drug to fight aging purges the body of damaged ‘zombie cells’

A drug to fight aging may finally be on the horizon after the first trials in humans showed “impressive” results. For many years, scientists have known that an accumulation of senescent cells in the body is linked to aging symptoms such as frailty and arthritis, as well as diseases such as Alzheimer’s and Parkinson’s. Senescent… Read More »

Is Amarin’s Fish-Oil-Derived Drug A Historic Breakthrough Or Not? It’s Complicated

Vascepa is not just any fish oil, and is different from over-the-counter supplements. Here’s a picture of a salmon jumping over the Goldstream River.Getty Cardiologists are still grappling with clinical trial results released last week that showed that Vascepa, a fish-oil-derived drug, reduced heart attacks, strokes, and deaths from cardiovascular disease by 25% in patients… Read More »